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1. Introduction 
The development of new chemical compounds with promising pharmacological activities is 
a very time-consuming and costly process because it requires many studies and evaluations 
prior to obtaining final approval for use in humans. Thus, for the safe use of any new drug, 
it is necessary to first know its physical, chemical and biological properties, as well as its 
efficacy, stability, pharmacokinetic properties (i.e., absorption, distribution, metabolism and 
excretion) and toxicity. 
Usually, the toxicity of a new drug or of its metabolites is the main reason most candidate 
drugs are removed from the development process and are not approved for human use. For 
this reason, it is very important to determine in the early development stages the tendency 
of a drug of interest to undergo bioactivation into toxic metabolites and, additionally, the 
reactivity of these metabolites toward biomolecules (Baumann & Karst, 2010). Therefore, an 
ideal drug metabolism study should include a complete identification of all metabolites 
generated and their bioactivation pathways, in addition to the reactions between the drug 
and its metabolites with endogenous molecules or xenobiotics. For this purpose, different in 
vitro and in vivo experimental models are commonly applied prior to clinical trials, which 
include the use of enzymes, liver cells, liver cell extracts and laboratory animals, among 
others (Brandon et al., 2003). 
Rat and human liver microsomes (RLM and HLM) are the most widely used cell extracts for 
studying metabolic reactions because they contain high concentrations of the cytochrome 
P450 enzymatic complex (CYP), which catalyzes the majority of oxidative reactions in 
organisms (Brandon et al., 2003). However, the use of conventional in vitro and in vivo 
methods makes it very difficult to detect the formation of reactive metabolites or 
intermediates with short half-lives because these short-lived species tend to covalently bond 
to cellular macromolecules, such as proteins and DNA (Lohmann & Karst, 2007). For this 
reason, the early 1980s ushered in the development and application of new methods for 
studying drug metabolism. In this context, the use of electrochemistry, a purely 
instrumental technique, has emerged as an interesting alternative to generate and detect 
metabolites in the drug development process because it can mimic the predominant redox 
reactions that occur in the human body (Álvarez-Lueje & Bollo, 2010; Jurva et al., 2003).  
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Electrochemistry is useful for the study of metabolism, as it has certain advantages 
compared to conventional methods. Namely, it allows the generation and direct 
identification, in a rapid and clean manner, of both stable species and metabolites with short 
half-lives. Consequently, electrochemistry can be a powerful tool in interaction studies with 
specific cellular components, which is more difficult to realize with conventional in vivo or in 
vitro methods. Additionally, electrochemistry is a cost-effective, rapid and clean system that 
does not require the use of laboratory animals or organ extracts. 
Different electrochemical methods have been applied to mimic drug metabolism and the 
reactivities of metabolites toward biomolecules, but the most frequently used system 
consists of an electrochemical cell coupled to a mass spectrometer (EC-MS). A modification 
of this system has involved the incorporation of a chromatographic separation between the 
cell and the detector, which permits on-line electrochemistry-liquid chromatography-mass 
detection (EC-LC–MS) (Lohmann et al., 2010). To improve this system and obtain more 
information about metabolic reactions, different modifications have also been utilized. For 
example, the incorporation of trapping agents (i.e., glutathione (GSH) or other thiols) that 
can form stable adducts with the reactive intermediates generated in the electrochemical cell 
is commonly used to detect the interactions of metabolites (Lohmann & Karst, 2006; van 
Leeuwen et al., 2005; Lohmann & Karst, 2009). Other electrochemical applications useful for 
metabolic studies include the development of enzyme-based biosensors, antibodies and 
DNA, among others (Joseph et al., 2003).  
In the following sections, the most important electrochemical aspects that can help explain 
how metabolic reactions can be emulated using different electrochemical methods and the 
advantages of these over conventional methods are presented. Additionally, the main 
metabolic pathways that can be electrochemically emulated and comparisons with in vivo 
and in vitro assays are summarized and discussed. Finally, both the application of 
electrochemical tools for studying interactions between metabolites and biomolecules and 
the application of biosensors in this field are presented. 
2. General aspects of electrochemistry 
Electrochemistry involves the study of chemical phenomena associated with the separation 
and transfer of charge that occurs at the interface of an electrode and solution. 
Electrochemistry is applicable in areas ranging from basic studies to environmental and 
clinical applications (Speiser, 2007). 
Electron transfer causes the reduction or oxidation of a substance when a sufficiently 
negative or positive potential is applied, respectively. As the potential values can be 
controlled externally, redox processes of interest can be carefully chosen, making 
electrochemistry useful for studying the redox behavior of any substance, inorganic or 
organic, including drugs, toxics, biomolecules and metabolites. 
Commonly, measurements are realized in an electrochemical cell using a system of three 
electrodes, the working, reference and auxiliary electrodes, immersed in a solution 
containing the compound of interest and a supporting electrolyte. The working electrode is 
usually constructed from inert materials, such as allotrope derivatives of carbon (graphite or 
glassy carbon) or metals (mercury, platinum or gold). Reference electrodes provide a fixed 
potential against which the potential applied to the working electrode is measured and 
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controlled, and they often consist of a saturated calomel electrode or Ag/AgCl(sat). A third 
electrode, the auxiliary electrode, is often included, which normally consists of a platinum 
wire. Because the reference electrode has a constant potential value, any change in the 
electrochemical cell is due to the working electrode and the redox process. The three 
electrodes are connected to a potentiostat, which controls the potential applied to the 
working electrode, and the results are recorded by a computer (Bard & Faulkner, 2001; Brett 
& Oliveira Brett, 1993). A schematic representation of this system is shown in figure 1A.  
 
Fig. 1. A) Electrochemical cell with a three-electrode system. B) Typical redox couple obtained 
using cyclic voltammetry on levodopa and the respective oxidative and reductive reactions. 
Different techniques are often employed in electrochemistry for the study of electroactive 
substances. These include linear sweep, differential pulse and cyclic voltammetry, 
chronoamperometry, chronocoulometry and bulk electrolysis, among others. All of these 
techniques can provide important information about substances of interest and the 
characteristics of their redox processes, but voltammetric and electrolytic methods are more 
relevant to the study of electroactive drugs, their metabolites and the metabolites’ 
interactions with biomolecules. 
Voltammetric methods are based on measuring changes in current by applying a fixed 
potential, or a potential sweep, onto the working electrode. According to the potential 
applied, the compound under study is oxidized or reduced at the electrode surface, while 
the bulk of the solution remains unchanged. Voltammetric measurements are two-
dimensional, where the potential is related to the qualitative properties of the substance, and 
the current is related to its quantitative properties. 
In linear sweep and pulse voltammetry, the potential sweep is applied in one direction only. 
However, the cyclic voltammetry technique makes successive potential sweeps in both 
directions, i.e., oxidation and reduction, between two potential values. A typical cyclic 
voltammogram is shown in figure 1B. Thus, cyclic voltammetry is useful for the study of 
both the redox properties of a substance and the behavior of the product generated during 
the electrochemical reaction. The applicability of this technique mainly depends on the 
number of compounds that are electroactive in the potential range applied, among other 
parameters. One highlight of cyclic voltammetry is that the rate of experiments can be 
regulated and, as a result, can be rapidly performed, allowing the study of species with 
short half-lives. 
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When the controlled potential electrolysis technique is used, a fixed potential is applied to 
the working electrodes, which have large surfaces so that the entire bulk solution can be 
oxidized or reduced. As a result, measurable amounts of compounds that are identifiable by 
other techniques, e.g., mass spectrometry, can be obtained. Thus, electrochemistry coupled 
to mass spectrometry (EC-MS) permits the reproduction of the redox reactions involved in 
drug metabolism, allowing the detection of final products or stable intermediaries 
(Lohmann et al., 2010). 
Taking into account that electrochemistry allows investigations of the redox reactions that 
drugs undergo and that phase I metabolism in the liver occurs via redox reactions, 
electrochemical methods have emerged as a promising alternative and a complementary 
tool in the study of in vitro metabolism because they are relatively simple, fast and cost-
effective systems. 
3. In vitro mimicry of metabolic reactions by electrochemistry 
The electrochemical oxidations of organic compounds and the use of electrochemistry to 
mimic biologic reactions, such as oxidative drug metabolism, have been well documented 
and revised (Álvarez-Lueje & Bollo, 2010; Jurva et al., 2000, 2003). Electrochemistry has been 
used to emulate different phase I reactions, such as aromatic hydroxylation, 
dehydrogenation and O- and N-dealkylation, by introducing the compound of interest into 
an electrochemical cell and applying a specific potential for a determined period of time. 
During this time, the entire sample is oxidized to generate one or more products, depending 
on the applied potential. Thus, from this method, the generated products can be identified, 
characterized and studied separately. Furthermore, the simulation of phase II reactions, 
including conjugation with GSH or other thiols from electrochemically generated phase I 
metabolites, has also been achieved. For example, the metabolism of clozapine, including 
both phase I and phase II reactions, has successfully been mimicked (van Leeuwen et al., 
2005), as well as the detoxification of acetaminophen (Lohmann & Karst, 2006) and the 
conjugation of diclofenac (Madsen et al., 2008a) by the electrochemical oxidation of the 
parent drugs. 
The replication of drug metabolism using electrochemistry is a faster, more cost-effective 
instrumental technique than the widely used in vivo and in vitro methods that utilize liver 
cells or isolated enzymes. On-line EC-MS has been introduced as an alternative for early-
stage metabolite discovery, and its ability to mimic biological oxidation patterns is currently 
being explored because it allows both the oxidation of a drug and the identification of the 
oxidized species. In this on-line system, the sample flows through an electrochemical cell 
that normally contains a working electrode made of porous glassy carbon, which posses a 
great area. On the working electrode occurs the quantitative conversion of the tested 
compound, depending on the working conditions, such as the nature of the analyte, the 
potential applied, the flow rate and the pH. Especially in high-throughput screening, EC-MS 
is superior to the conventional methods, as it can be completely automated. Because of these 
features, on-line EC-MS is of particular importance to the pharmaceutical industry. 
Although the EC-MS results are not completely transferable to the conditions of the human 
liver, this methodology can provide primary data concerning the metabolism of drugs in the 
human body. Thus, the instrumental method EC-MS may have advantages or may be 
complementary to the existing methods of screening that involve in vitro studies or organ 
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fractions, e.g., microsomes, hepatocytes and liver slices. Additionally, with an on-line EC-
MS system, the complexity of a biological system is reduced, and the optimization of the 
electrochemical and MS parameters can be realized more rapidly. The ternary combination 
of EC-LC-MS is able to detect reaction products with lifetimes on the order of several 
minutes; therefore, short-lived intermediates are not detected, as they react to more stable 
products during the chromatographic run. Direct EC-MS allows the detection of less stable 
compounds with lifetimes of a few seconds (van Leeuwen et al., 2005). In figure 2, a 
schematic representation of both systems is shown. 
              
Fig. 2. Schematic representation of different on-line electrochemical set-ups used for the 
study of drug metabolism reactions. A) EC-MS system; B) EC-LC-MS system (adapted from 
Baumann & Karst, 2010). 
The use of on-line EC-MS began in the early 1970s. Early studies included the development 
of a thin-layer electrochemical flow cell that was employed in combination with 
thermospray mass spectrometry for the study of the oxidation of uric acid and 6-
thioxanthine (Volk et al., 1989, 1992). An analogous array in a flow injection experiment was 
used to study the formation of GSH and cysteine conjugates of acetaminophen. Later, the 
pattern of coupling an electrochemical flow cell to mass spectrometry was extended to other 
ionization techniques, e.g., fast-atom bombardment, particle beam, atmospheric-pressure 
chemical ionization and electrospray (Baumann & Karst, 2010; Jurva et al., 2000; Lohmann et 
al., 2008). 
The first coupling of electrochemistry to particle-beam mass spectrometry was applied for 
the study of the oxidation pathway of dopamine (Regino & Brajter-Toth, 1997). Later, 
different electrochemical cells were coupled to an electrospray mass spectrometer to study 
the different products of biologically relevant redox reactions (Zhou & Van Berkel, 1995). In 
addition, an on-line electrochemistry-electrospray ionization mass spectrometry system 
using a microflow electrolytic cell was developed and applied to study the electrochemical 
oxidation of caffeic acid (Arakawa et al., 2004). 
The first example of the application of EC-LC-MS for the study of drug metabolism was 
reported in 1989 for comparing the enzymatic and electrochemical oxidation pathways of 
uric acid. This study found that the enzymatic and chemical reactions yielded the same 
intermediates and products of those observed in the electrochemical oxidation. A similar 
array was used to oxidize 3-hydroxy-dl-kynurenine (a tryptophan metabolite) in an 
electrochemical cell, eventually separating the oxidation products by reversed-phase LC and 
identifying the products by UV and MS detection (Deng & Van Berkel, 1999). 
Comparisons on the mechanistic level have been made for most reactions to explain why 
certain reactions can and other reactions cannot be mimicked by electrochemical oxidations. 
The EC system successfully mimics metabolic pathways in cases where the CYP-catalyzed 
reactions are supposed to proceed via a mechanism initiated by one-electron oxidation, such 
as N-dealkylation, S-oxidation, P-oxidation, alcohol oxidation, dehydrogenation and 
EC cell
MS 
detector
Potentiostat
Drug EC cell LC column
MS 
detector
Potentiostat
Drug
A B 
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hydroxylation of aromatic rings that contain electron-donating groups. In contrast, the CYP-
catalyzed reactions initiated via direct hydrogen abstraction, such as O-dealkylation, 
aliphatic hydroxylation and hydroxylation of aromatic rings without electron-donating 
groups, generally have a very high oxidation potential for electrochemical oxidation and 
cannot always be mimicked using EC (Johansson et al., 2007). However, even when the EC 
system is not able to mimic all oxidations performed by CYP, valuable information can be 
obtained regarding the sensitivity of the substrate toward oxidation and the molecular 
position where oxidation is likely to occur. 
For the reason described above, to be able to mimic all CYP-catalyzed oxidations, 
electrochemistry must be complemented with other oxidative systems. This is the case for 
the electrochemically assisted Fenton reaction (EC-Fenton) that is able to mimic aliphatic 
hydroxylation, benzylic hydroxylation, aromatic hydroxylation, N-dealkylation, N-
oxidation, O-dealkylation, S-oxidation and dehydrogenation (Johansson et al., 2007). In EC-
Fenton, the regeneration of Fe+2 is achieved by the reduction of Fe+3 at the working 
electrode. The hydroxyl radical generated from this system is highly electrophilic and 
readily reacts with aromatic rings and double bonds. In addition, the hydroxyl radical can 
abstract a hydrogen atom from various organic compounds. 
Studies on drug metabolism by electrochemical techniques will be presented, discussed and 
compared with conventional in vitro (e.g., microsomes, hepatocytes and porphine system) 
and in vivo assays and divided by each main representative chemical functional group, 
including aliphatic hydroxylation; aromatic hydroxylation; N-, S- and O-dealkylations; 
heteroatom (N, S and P) oxidation; dehydrogenation; and other oxidative reactions, such as 
the oxidations of alcohols, aldehydes and benzylic groups. In addition, examples of drug 
metabolism mimicked by EC are summarized in table 1. 
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Acetaminophen Phases I, II N-acetyl-p-
benzoquinoneimine 
p-benzoquinoneimine-
GSH 
  
 
 
√ 
√  
√ 
√ 
Lohmann & 
Karst,2006; 
Madsen et al., 
2007 
Albendazole Phase I albendazole sulfoxide 
albendazole sulfone 
 
√# 
√# 
√ 
√ 
√ 
√  
√ 
√ 
Galvão de Lima et 
al., 2003 
Amodiaquine Phases I, II N-deethylated 
quinoneimine 
Quinoneimine 
Aldehyde 
GSH adducts 
N-deethylation 
  
√ 
√ 
√ 
√ 
√ 
× 
√ 
× 
√ 
√ 
 
√ 
√ 
√ 
√ 
√ 
Johansson et al., 
2007; Johansson et 
al., 2009; Lohmann 
& Karst,2007; 
Madsen et al., 
2007  
Boscalid Phases I, II hydroxylation, 
dehydrogenation 
GSH adducts 
√* 
√*     
√ 
√ 
Lohmann et al., 
2009 
Chlorpromazine Phase I N-demethylation 
S-oxidation 
 N-oxidation 
aromatic 
hydroxylation 
   
√ 
√ 
√ 
√ 
 
√ 
√ 
× 
× 
Nozaki et al., 2006 
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Clozapine Phases I, II N- dealkylation 
N-oxide 
aromatic 
hydroxylation 
GSH adducts 
√#√#
√# 
√# 
 
√ 
√ 
× 
√ 
√ 
√ 
× 
√ 
 
√ 
× 
√ 
√ 
Dain et  al., 1997; 
Schaber et al. 2001; 
van Leeuwen et 
al., 2005;  
Diclofenac Phases I, II 4’-OH- diclofenac
5-OH-diclofenac 
GSH adducts 
  
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
Madsen et al., 
2008a 
Estradiol Phases I, II 2-hydroxyestradiol
4-hydroxyestradiol 
GSH adducts 
  
√ 
√ 
√ 
√ 
√ 
√ 
 
√ 
√ 
√ 
Gamache et al., 
2003 
7-ethoxycoumarin Phase I O-dealkylation
  √ √ √ √ 
Johansson et al., 
2007; Jurva et al., 
2000;  
Lidocaine Phase I N- dealkylation
N-oxidation 
  
× 
√ 
√ 
√ 
√ 
× 
√ 
√ 
Baumann & Karst 
2010; Johansson et 
al., 2007; Jurva et 
al., 2003;  
Mephenytoin  Phase I dydroxylation
  √ √  √ Johansson et al., 
2007 
S-
methylthiopurine 
Phase I S-oxidation
S-demethylation   
√ 
√ 
√ 
√  
√ 
√ 
Johansson et al., 
2007 
Metoprolol Phase I benzylic hydroxylation
aromatic 
hydroxylation 
N-dealkylation 
O-dealkylation
  
√ 
√ 
√ 
√ 
√ 
× 
√ 
√ 
 
√ 
√ 
√ 
√ 
Baumann & Karst 
2010; Johansson et 
al., 2007  
Mitoxantrone  Phase I quinone
  √   √ Lohmann & Karst, 
2007 
Parathion  Phase I phosphine oxide √*     √ Jurva et al., 2003 
Procainamide  Phase I N-monodealkyl 
procainamide 
N-hydroxylamine 
procainamide 
N-oxide derivative 
procainamide
  
× 
√ 
√ 
√ 
√ 
× 
 
√ 
√ 
√ 
Odijk et al., 2010 
2-(N-propyl-N-2-
thienylethyl 
amino) -5-
hydroxitetralin 
Phase I N-dealkylation
hydroxylation 
  
√ 
√   
√ 
√ 
Jurva et al., 2000 
Testosterone  Phase I aliphatic hydroxylation
  √ √  √ Johansson et al., 
2007 
Tetrazepam Phase I cyclohexenyl 
hydroxylations  
3-hydroxytetrazepam 
diazepam 
nortetrazepam
√# 
×# 
√# 
√# 
 
√ 
√ 
√ 
√ 
  
√ 
√ 
√ 
√ 
Baumann et al., 
2009 
Toremifene Phases I, II N-demethylation
N-oxide 
quinone methide 
GSH adducts 
  
√ 
√ 
√ 
√ 
√ 
√ 
√ 
√ 
 
√ 
× 
√ 
√ 
Lohmann & Karst, 
2009 
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Triclocarban Phase I 2’-hydroxytriclocarban
6-hydroxytriclocarban 
3’-hydroxytriclocarban
2’,6-
dihydroxytriclocarban 
3’,6-
dihydroxytriclocarban
√# 
√# 
√# 
√* 
 
√*#
√*#
 
 
 
√ 
√ 
√ 
× 
× 
√ 
√ 
√ 
× 
× 
√ 
√ 
 
 
 
√ 
√ 
√ 
√ 
√ 
Baumann et al., 
2010 
Troglitazone Phases I, II p-quinone derivative
o-quinone methide 
o-quinone methide 
conjugates 
 
√# 
×# 
 
× 
√ 
√ 
√ 
√ 
√ 
 
√ 
√ 
√ 
Madsen et al, 
2008b; Tahara et 
al., 2007; Tahara et 
al., 2009 
Zotepine Phase I N-demethylation
S-oxidation 
N-oxidation 
aromatic 
hydroxylation
   
√ 
√ 
√ 
√ 
 
√ 
√ 
× 
× 
Nozaki et al., 2006 
Table 1. Examples of drug metabolism mimicked by EC (√: generated; ×: not generated,*rat, 
#human). 
Aliphatic hydroxylation 
 
One limitation of the electrochemical method has been the difficulty in mimicking the 
metabolic hydroxylation of alkanes and alkenes due to the fact that electrochemical 
oxidation potentials for aliphatic hydrocarbons are generally very high (Jurva et al., 2003).  
Nevertheless, there have been some examples where this experimental limitation has been 
overcome, as in the oxidation of the muscle relaxant tetrazepam. In this case, a platinum 
working electrode was used, with an enhanced potential range of up to 2000 mV, instead of 
the typical porous glassy carbon working electrode, and the hydroxylation of the 
tetrazepam cyclohexenyl group at five different positions was successfully achieved 
(compounds 2, 3, 6, 8 and 10 in figure 3). In this study, an on-line EC-LC-MS system was 
used to analyze the metabolic pathway of the drug. Additionally, a comparison of the EC 
method with urine analyses and a conventional rat liver microsomal approach was 
performed, which found that eleven different metabolites were indentified in the urine 
samples, and only two of them were not found after microsomal incubation (table 2). These 
differences were explained as a result of different CYP isoforms with different catalytic 
activities in each organism; therefore, the metabolism in humans and in rat liver microsomes 
may result in different metabolites or a different distribution of them. As can be seen in this 
example, the comparison of both methods shows that electrochemistry combined with LC-
MS is an adequate complementary tool to conventional in vitro methods in the prediction of 
metabolic processes of tetrazepam (Baumann et al., 2009).  
A second example of aliphatic hydroxylation is testosterone, in which two different 
hydroxylation products were found in liver microsomes, one in RLM and the other in HLM. 
Both metabolites were generated using the EC-Fenton system and the porphine system 
(Johansson et al., 2007). 
R CH2 CH3 R CH CH3
OH
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Fig. 3. Oxidative metabolism of tetrazepam (adapted from Baumann et al., 2009). 
 
 Compound 
 1 2 3 4 5 6 7 8 9 10 11 12 
Urine x x x x x x  x x x x x 
RML x x x x   x x x x x x 
EC  x x  x x x x x x x x 
Table 2. Tetrazepam metabolites produced in different systems. For compound 
identification, see figure 3 (adapted from Baumann et al., 2009). 
Aromatic hydroxylation 
 
Contrary to aliphatic hydroxylation, a variety of drugs and compounds have been tested for 
aromatic hydroxylation using EC-MS, including coumarin, p-nitrophenol, diclofenac, 
xanthohumol, tyramine and N,N-dimethylaniline (Jurva et al., 2003). 
In general, to be oxidized electrochemically within the potential limits of water, the aromatic 
ring must be activated by an electron-donating group (e.g., a hydroxyl or amino group). For 
an aromatic ring without an electron-donating group, the starting compound is more 
difficult to oxidize than the product. For example, benzene is oxidized at a potential 
approximately 1300 mV more anodic than phenol. Furthermore, the oxidation cannot be 
stopped at the phenol stage but instead proceeds immediately to benzoquinone (figure 4). 
The hydroxylation of aromatic compounds by CYP shows some mechanistic similarity to 
electrochemical oxidation. However, due to the lack of an active iron-oxygen species in the 
electrochemical system, the radical intermediate achieved after the initial oxidation and 
deprotonation steps will react further in different pathways, which are determined by the 
specific substituents (Jurva et al., 2003). 
R
OH
R
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Fig. 4. Electrochemical oxidation mechanism of phenols. 
The suggested mechanism for the electrochemical oxidation of phenols (figure 4) is initiated 
in the same way as the CYP-catalyzed oxidation. Compounds that are easily 
electrochemically oxidized likely follow this pathway for CYP-catalyzed oxidation, while 
compounds with high oxidation potentials are more likely to proceed via one of the other 
pathways after oxidation by CYP. In an electrochemical system, the nature of the π-system, 
the physical features of the working electrode and the nature of the supporting electrolyte 
will determine the final compound. Thus, different substituents on the aromatic ring 
frequently result in different products, e.g., phenols are generally oxidized to quinones, 
while other substituents on the aromatic ring will lead to different products.  
The beta blocker metoprolol and the antiepileptic mephenytoin are good examples of 
compounds in which aromatic hydroxylation has been investigated. Metoprolol contains an 
aromatic ring with oxygen as an electron-donating group. In contrast, mephenytoin does not 
contain any strong electron-donating groups, and it represents an aromatic ring with lower 
electron density. The aromatic hydroxylation of metoprolol has been studied in RLM, and it 
was also simulated using a conventional EC system, the EC-Fenton system and the porphine 
system (figure 5). A different situation occurred with mephenytoin, whose aromatic 
hydroxylation has been investigated in both RLM and HLM but could only be mimicked 
using the EC-Fenton system and the porphine system (Johansson et al., 2007). 
 
Fig. 5. Metabolism of metoprolol in HLM (Johansson et al., 2007). 
The hydroxylation of estrogens has also been investigated in an EC system. Investigations 
with estradiol, which was subjected to EC oxidation, were interesting and produced two 
hydroxylated metabolites, 2-hydroxyestradiol and 4-hydroxyestradiol (figure 6) (Gamache 
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et al., 2003). It has been shown that 2-hydroxylation of estradiol to its catechol derivative is a 
major metabolic pathway in rodent and human livers, whereas 4-hydroxylation to a 
different catechol represents a minor pathway in the liver. It has also been demonstrated 
that 2-hydroxylation is the major hydroxylation pathway in HLM, while the rate of 4-
hydroxylation is 1/4 to 1/6 of that for the 2-hydroxylation of estradiol (Zhu & Lee, 2005). 
 
Fig. 6. Hydroxylation of estradiol produced by the EC system at 900 mV as well as in RLM 
and HLM. 
N-, S- and O-Dealkylations 
 
The dealkylation of amines and ethers can be replicated by EC systems. While the former 
can be readily mimicked, the dealkylation of ethers can only be obtained in low yields. 
However, the dealkylation of thioethers cannot yet be mimicked using EC. 
The dealkylation of alkylamines is the main pathway in both EC and enzymatic oxidation. 
The parent compound undergoes one-electron oxidation to yield a heteroatom-centered 
cation radical. The cation radical is better stabilized by sulfur and phosphorus than by 
nitrogen. As a consequence, the main products from CYP-catalyzed oxidation and from EC 
oxidation are sulfoxides and phosphine oxides. If the heteroatom is oxygen, CYP is not able 
to complete a one-electron oxidation due to the poor ability of oxygen to carry the positive 
charge. Thus, the reaction proceeds via a direct hydrogen abstraction from the ǂ-carbon. In 
the proposed mechanism for the EC oxidation of aliphatic amines (figure 7), the first two 
steps are the same for EC and CYP-catalyzed oxidation. One-electron oxidation gives an 
iminium cation radical, which produces the ǂ-carbon-centered radical. In the CYP-catalyzed 
mechanism, the electron and the proton are transferred to the iron-oxygen of the enzyme, 
and the hydroxyl group is introduced to the ǂ-carbon by reacting with the [Fe–OH]3+ 
species. In the EC oxidation, the electron is transferred to the working electrode, and the 
proton is lost to any compound acting as a base in solution. Because there is no active iron-
oxygen intermediary present in the EC system, the neutral radical is further oxidized at the 
working electrode to the iminium ion. Finally, hydrolysis of the iminium ion provides the 
dealkylated amine and the corresponding aldehyde (Jurva et al., 2003). 
Many drugs contain substituted amine groups. For example, metoprolol undergoes N-
dealkylation of the secondary amine and generates a product corresponding to a loss of its 
isopropyl group. This has been observed in both RLM and HLM, and the reaction has been 
successfully mimicked using conventional EC, EC-Fenton and porphine systems (figure 5). 
However, N-deethylation of the tertiary amine function of lidocaine has been observed in 
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HLM, and the same N-dealkylation was demonstrated for amodiaquine in RLM and HLM. 
Such N-dealkylation reactions were successfully mimicked in the EC system for lidocaine, 
while for amodiaquine, the reaction was mimicked in the EC and EC-Fenton systems 
(Johansson et al., 2009; Lohmann & Karst, 2007). 
Fig. 7. Electrochemical oxidation mechanism of aliphatic amines. 
More recently, an on-chip electrochemical cell was developed for routine use in drug 
metabolism studies. The chip was used for the metabolism study of the known 
antiarrhythmic drug procainamide, which found that the chip was able to generate all of the 
known metabolites produced in both RLM and HLM (figure 8). In the RLM incubation 
mixture, the metabolites N-hydroxylamine and N-oxide derivatives were identified. In 
contrast, in the HLM incubation mixture, the dealkylation product N-deethyl procainamide 
and the oxygenation product N-hydroxylamine derivative were detected. Using an on-line 
system consisting of the on-chip electrochemical cell, LC separation and subsequent MS 
detection, the metabolism of procainamide was achieved. In this case, on-chip oxidation 
actually demonstrated the ability to provide more information about the generated 
metabolites in a single experiment than the microsomal studies (Odijk et al., 2010). 
 
Fig. 8. Oxidative metabolism of procainamide (adapted from Odijk et al., 2010). 
Finally, examples of O-dealkylations obtained from EC oxidation include metoprolol, which 
undergoes O-demethylation (figure 5), and 7-ethoxycoumarin, which generates its 
corresponding O-deethyl derivative. For both drugs, the same reactions have been found in 
RLM and HML (Johansson et al., 2007). 
Heteroatom (N, S, P) oxidation 
 
As a general rule, S-oxide and N-oxide formation can be successfully mimicked using EC, 
but unlike the formation of S-oxides, N-oxide formation can only be detected in low yields. 
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Thus, heteroatom (N, S and P) oxidation has successfully been proven for different drugs 
when compared with the typical in vitro systems. In all cases, the three types of oxidation 
were observed in both RLM and HLM, and the oxidation was mimicked in the EC, EC-
Fenton and porphine systems. Typical examples of such reactions include lidocaine (N-
oxidation) and S-methylthiopurine (S-oxidation). In figure 9, representative reactions of each 
type are presented. In heteroatom oxidation, the porphine system and the EC-Fenton system 
are preferable due to higher yields of the oxidation product than the EC-system (Jurva et al., 
2003). 
 
Fig. 9. Typical examples of heteroatom oxidations. A) lidocaine (N-oxidation), B) S-
methylthiopurine (S-oxidation) and C) parathion (P-oxidation). 
Compounds containing phosphorus generally have a lower oxidation potential than sulfur-
containing compounds, and CYP-catalyzed oxidation and electrochemical oxidation of 
phosphorus-containing compounds almost exclusively result in phosphine oxides. An 
example of this kind of reaction is the CYP-catalyzed phosphothionate oxidation of the 
pesticide parathion (figure 9). Indeed, electrochemical oxidation of parathion yielded the 
same oxidation product at a potential of 600 mV in 0.1 M acetic acid (Jurva et al., 2003). 
Dehydrogenation 
 
Dehydrogenation reactions can be readily mimicked using EC, especially when followed by 
quinone or quinone imine formation. Acetaminophen is oxidized by several human CYP 
enzymes to its toxic metabolite N-acetyl-p-benzoquinoneimine. The dehydrogenation of 
acetaminophen has been mimicked by the EC system as well. The proposed mechanism for 
its EC oxidation included the formation of a radical intermediary, likely via electron transfer 
followed by proton abstraction. Then, another one-electron oxidation followed by a second 
proton abstraction yields the final product. This mechanism for EC oxidation is nearly the 
same as the suggested enzymatic mechanism (Jurva et al., 2003). 
A similar reaction occurs with the oxidation of the aminophenol moiety of the antimalarial 
agent amodiaquine to form the quinoneimine derivative (shown in figure 10). This has been 
observed in both RLM and HLM, and mimicry has been achieved with the EC-system, the 
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EC-Fenton system and the porphine system. The generated quinoneimine is an electrophilic 
species that reacts with nucleophiles present in the system. Therefore, cysteine is usually 
added to all of the systems, and the detection of amodiaquine cysteinyl conjugates is 
evidence of quinoneimine formation (Johansson et al., 2007; Lohmann & Karst, 2007). 
Other oxidation reactions 
Alcohol and aldehyde oxidation. Metoprolol has also been used to illustrate alcohol and 
aldehyde oxidation. Presumably, the formation of the final carboxylic metabolites from the 
O-demethylation of metoprolol, shown in figure 5, includes alcohol oxidation to the 
corresponding aldehyde, which is followed by aldehyde oxidation to carboxylic acid. Both 
alcohol and carboxylic derivatives have been found in RLM and HLM. These derivatives 
were mimicked in the porphine system, but only the O-demethylated derivative has been 
generated in the EC and EC-Fenton systems. The aldehyde derivative that comes from the 
oxidation of the side chain of metoprolol (figure 5) has been successfully obtained using EC, 
EC-Fenton and porphine systems but has only been observed in RLM (Baumann & Karst 
2010; Jurva et al., 2003). 
Benzylic hydroxylation. This kind of oxidative reaction has been mimicked using EC, EC-
Fenton and the porphine systems for metoprolol. This metabolite (in figure 5), which is 
formed through benzylic hydroxylation, is the major hydroxylated metabolite of metoprolol 
in both RLM and HLM (Baumann & Karst 2010; Jurva et al., 2003). 
 
Fig. 10. Formation of the quinoneimine derivative from amodiaquine. 
4. Interaction studies 
Drug metabolism is regarded as a process that contributes to detoxification, but in some 
cases, the produced metabolites are reactive species that are more toxic than the parent 
drug. These reactive intermediates, which are classified as electrophiles and free radicals, 
can covalently bond to certain endogenous molecules, resulting in cell damage and toxicity.  
The application of cyclic voltammetry can provide a first approach to study the reactivities 
of electrochemically generated species toward endogenous molecules, such as GSH, proteins 
and DNA. Usually, incubation with biomolecules in an electrochemical cell produces the 
appearance or disappearance of electrochemical signals in typical voltammograms of the 
drug of interest. These changes are due to adduct formations between the reactive species 
and the biomolecules, which could be part of the biological detoxification process. 
Furthermore, this technique allows an estimate of the electrochemical potential necessary to 
generate a desired product from the oxidation or reduction of its parent compound. 
Nevertheless, the small amount of electrolyzed product obtained from this technique does 
not allow the identification of the adducts formed. For this reason, the controlled potential 
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electrolysis technique is useful for generating considerable amounts of reactive 
intermediaries, thereby facilitating the identification of adducts formed using other 
techniques, e.g., MS. 
In this sense, EC-MS and EC-LC-MS systems allow the electrochemical generation and 
direct detection of reactive intermediaries that are short-lived and unstable, which are 
difficult to detect using the conventional methods of studying drug metabolism. The 
incorporation of biomolecules into the electrochemical cell or between EC and MS, as is 
presented in figure 11, is useful for determining the reactivity of metabolites and the 
respective adducts formed. This system has already been applied to study the interactions 
between endogenous molecules, especially with GSH, making it possible to establish 
relationships and obtain more information about phase II metabolism and drug 
detoxification mechanisms. 
 
Fig. 11. Schematic representation of the on-line EC-LC-MS system to study adducts 
formation with GSH or other biomolecules (adapted from Baumann & Karst, 2010).  
By using an on-line system, it has been possible to mimic metabolic reactions that involve 
phase I oxidation products and phase II conjugates of different drugs, such as clozapine, 
acetaminophen, toremifene, amodiaquine and mitoxantrone, among others (table 1). Some 
examples of interaction studies and the importance of the information obtained are 
described below. 
The antipsychotic drug clozapine undergoes extensive hepatic metabolism, with the major 
metabolites found in humans being clozapine N-oxide and N-demethylclozapine. In 
addition, many other metabolites and adducts have been identified in humans and rats. 
Cyclic voltammograms of clozapine have shown one signal in the oxidative scan direction 
(O1 at 450 mV) and two signals in the reverse scan (R1 at 390 mV and R2 at 75 mV) (figure 
12). The potential difference between the O1 and R1 signals revealed a reversible redox 
process, which means that the oxidation product of clozapine (nitrenium ion) was reduced 
to the parent molecule. The second signal, R2, was attributed to a chemical reaction 
subsequent to the clozapine oxidation, with the formation of a new reduced species 
(hydroxylated). Upon repetitive scans, a new oxidation peak appeared (O2 at 300 mV), 
which was probably related to the oxidative process of the R2 product (quinone imine 
derivative). In the presence of GSH, the reduction peaks R1 and R2 disappeared completely 
in the presence of a ten-fold excess of GSH. These changes in the cyclic voltammetric profiles 
were due to adduct formations between GSH and the generated reactive intermediaries. 
Interestingly, upon increasing the GSH concentration, two new oxidation peaks appeared at 
potentials more positive than O1, which indicated that oxidation of the produced 
thioadducts occurred. 
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Using EC-MS and EC-LC-MS systems with a working electrode consisting of porous glassy 
carbon, different metabolites were obtained for clozapine, depending on the applied 
potential (figure 13). Upon oxidation to 400 mV, hydroxyl clozapine derivatives and 
nitrenium ions were the predominant products formed. Increasing the potential to 700 mV, 
the generation of an additional product, N-demethyl clozapine, was observed. No N-oxide 
derivative was detected by this system, probably because it was only generated to a small 
extent. When the oxidation of clozapine was performed in the presence of GSH, the 
formation of adducts between the metabolites that were generated and GSH were detected. 
These adducts were identified as hydroxy-GSH clozapine and GSH-demethyl clozapine. 
Additionally, a bis-GSH adduct and at least three isomers of a GSH-clozapine adduct were 
formed. Despite the fact that not all oxidative metabolic pathways of clozapine were 
mimicked by this system, the production of similar metabolites (phases I and II) confirmed 
the in vitro and in vivo reports concerning the metabolism of clozapine (van Leeuwen et al., 
2005). 
 
Fig. 12. Cyclic voltammograms of clozapine (A) without GSH and (B) with GSH (adapted 
from van Leeuwen et al., 2005). 
The most studied drug in metabolite-biomolecule interactions is acetaminophen, and it is a 
classic example of the importance of these studies to measure the potential metabolic 
toxicity of a substance. Acetaminophen is a drug that is well known to cause liver toxicity in 
humans by its oxidative metabolic pathway in which the highly reactive electrophile 
intermediate N-acetyl-p-benzoquinoneimine (NAPQI) is generated. This species is normally 
detoxified by conjugation with reduced GSH, but in an acetaminophen overdose, the total 
liver GSH is depleted. EC-MS and EC-LC-MS experiments using either acetaminophen 
alone or in the presence of GSH or N-acetylcysteine (NAC) have been conducted to study 
the detoxification pathway of acetaminophen. 
The electrochemical oxidation of acetaminophen leads to NAPQI, which is also observed in 
vivo. After applying a potential of 600 mV, at which acetaminophen shows an oxidation 
wave in cyclic voltammetry measurements, three major additional signals were observed in 
the presence of GSH or NAC, which indicated the formation of acetaminophen adducts. In 
the presence of these thiol-containing molecules, NAPQI was quenched by adduct 
formation (figure 14). This mechanism is the common detoxification pathway of NAPQI in 
the human liver. MS measurements showed only the formation of GSH and NAC 
monoadducts, but in each case, two different isomers were produced, which could 
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correspond to 2- and 3-conjugated-acetaminophen. In general, NAPQI has two possible 
reaction sites, namely, the 2- and 3-substitution positions. Unlike in the human body, only 
conjugates at position 2 of acetaminophen are formed. This selectivity is a result of the CYP 
enzymatic system that is involved in in vivo adduct formation, which is not possible to 
achieve using only electrochemical methods and trapping agents. Despite this, the 
electrochemical oxidation of acetaminophen, alone and in the presence of GSH or NAC, 
allowed the successful replication of the metabolic detoxification pathway that occurs in the 
human liver (Lohmann et al., 2006). 
 
Fig. 13. Electrochemical oxidation of clozapine (van Leeuwen et al., 2005). 
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A modification of the conventional on-line system was introduced to simulate conjugative 
phase II reactions. This system consisted of the incorporation of an enzymatic reactor 
between the electrochemical cell and the separation system and was applied to investigate 
the phase II metabolism of toremifene, a selective estrogen receptor modulator. 
It is well known that toremifene metabolism by CYP is comprised mainly of hydroxylation, 
O-dealkylation, N-dealkylation and N-oxide formation, which are observed in rat, mouse, 
and human liver microsomes. All are produced electrochemically, except for the N-oxide 
derivative (figure 15). Furthermore, the generation of reactive quinone methides may occur, 
which are detoxified by reacting with GSH, the reaction of which is catalyzed by 
glutathione-S-transferase (GST). 
 
Fig. 14. Detoxification mechanism of acetaminophen by adduct formation with GSH and 
NAC (Lohmann et al., 2006). 
Generally, the conjugation of quinoid compounds with GSH observed in phase II 
metabolism has been successfully mimicked by electrochemical methods because the 
conjugation proceeds spontaneously via a 1,4-Michael addition reaction. In the case of 
toremifene, the conjugation with GSH occurs by nucleophilic substitution of the chloride 
atom, which normally is not possible using electrochemical techniques, which suggests that 
this reaction requires enzymatic catalysis to proceed. However, using only an EC-LC-MS 
system with GSH incubation, it was possible to identify the adduct formed between GSH 
and the quinone methide derivative by chloride atom substitution. Furthermore, the 
incorporation of GST to the system made it possible to obtain an additional conjugate that is 
only generated by enzymatic catalysis. Thus, the use of metabolic enzymes in the on-line 
EC-LC-MS provided important information about metabolites that are not normally 
identified by conventional in vitro and in vivo assays or by simple electrochemical systems 
(Lohmann & Karst, 2009). 
Other interesting approaches that involved this on-line system included interaction studies 
of metabolites with more complex biomolecules, such as plasma proteins and DNA. To 
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perform and evaluate the covalent protein binding of reactive phase I metabolites, the 
oxidation products of acetaminophen, amodiaquine and clozapine have been evaluated 
with regard to adduct formation with beta-lactoglobulin A and human serum albumin. The 
experiments demonstrated that mainly covalent binding took place between the free thiol 
groups of these proteins and the reactive metabolites, which is analogous to endogenous 
detoxification pathways. Thus, this experimental system offered interesting features in the 
risk assessment of the covalent protein binding of drug metabolites due to the significance 
of the protein structure and its function (Lohmann et al., 2008). 
 
Fig. 15. Electrochemical oxidation of toremifene (Lohmann & Karst, 2009). 
In relation to reductive metabolism, the redox chemistry of different nitro compounds of 
biological significance have been studied to understand how the reduction of the nitro 
group can play an active role in free radical generation and free radical reactivity. Some 
drugs that were studied corresponded to calcium antagonists, antibacterial and 
antiprotozoan agents, among others (Squella et al., 2005). Cyclic voltammetric technique 
using mercury as the working electrode permitted the simulation of the enzymatic 
formation of the nitro radical anion, a product of the one-electron reduction of nitro 
compounds, and an evaluation of chemical and biological characteristics. 
Using this electrochemical technique, it was also possible to detect and quantify the 
interaction between the nitro radical anion derivative and several targets of biological 
significance, such as oxygen, thiols and DNA. In fact, the addition of a target compound 
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with which the nitro radical anion derivative could interact produced changes in the cyclic 
voltammetric response that could be used to quantitatively calculate the interaction constant 
value. One of the main advantages of cyclic voltammetry in the study of nitro radical anions. 
is that they can be generated and studied in situ (Bollo et al., 2000). 
5. Biosensors for metabolic reactions 
A biosensor is a device capable of detecting, recording and transmitting information about 
the presence, activity or concentration of a specific compound in solution with a biological 
recognition element and a physicochemical transducer (figure 16). These devices have 
become very important due to the advantages they possess as rapid tools for the screening 
and detection of substances and the possibilities of miniaturization that would allow the 
development of portable devices. 
As can be seen in figure 16, the biological recognition element can include enzymes, 
antibodies, cell receptors, tissues, or microorganisms, whereas the transducers that are often 
used are electrochemical, optical and piezoelectrical. The biorecognition process can either 
be a bio-affinity (affinity ligand-based biosensor) or bio-metabolism (enzyme-based 
biosensor) reaction, and this interaction results in biochemical and physicochemical changes 
that are converted to a quantifiable signal by the transducer. The biosensor selectivity for the 
target drug is mainly determined by the recognition element, while its sensitivity is greatly 
influenced by the transducer. In this sense, the most common biosensors are based on 
electrochemical transducers that confer high detection sensitivity (D’Orazio, 2003). In 
electrochemical biosensors, the main transducing elements include working electrodes of 
noble metals (e.g., platinum or gold) or carbon derivatives (e.g., glassy carbon or carbon 
paste). These electrodes can be modified to improve the connection to the recognizing agent, 
which would make them applicable to a large variety of samples.  
 
Fig. 16. Representation of a typical biosensor, including the different constituent parts. 
Although biosensors have been successfully developed and used in different areas, with the 
glucose biosensor being the most common example, their application in metabolism is 
relatively new, and most of the works in this area have focused on optimizing the 
immobilization process of the biological element. Because most electrochemical biosensors 
are based on enzymatic reactions, they are a promising strategy for studying metabolic 
reactions, particularly by CYP-catalyzed oxidations. For example, modified electrodes with 
CYP enzyme films could be used as a screening tool to study drug metabolism, focusing 
mainly on drug interactions with the enzyme and on the toxicity of metabolites toward 
biomolecules, such as proteins and DNA (Bistolas et al., 2005). 
A critical step in the construction of any biosensor is the immobilization of the biorecognition 
element onto the electroactive surface because an incorrect immobilization can lead to the loss 
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of the native structure and therefore a loss of activity of the biological compound. In general, 
direct electrochemistry of CYP enzymes on unmodified electrodes has proven very difficult 
due to the deeply buried heme cofactor and instability of the biological matrix upon 
interaction with the electrode surface. To solve this problem, an immobilization material can 
be used, which is often a membrane or matrix that acts only as a biological component support 
or that participates in the signal transduction system. In addition to this problem, when the 
CYP is used as the biorecognition element, an extra component to provide external electrons 
(e.g., flavin, iron–sulfur proteins or NAD(P)H) is required, which makes biosensor 
development more complex. Despite these limitations, there are results that suggest that 
human enzyme CYP3A4 immobilized onto a gold electrode is electrically and catalytically 
active (Joseph et al., 2003). Additionally, some authors have studied the possibility of a direct 
electrochemical delivery of the required electrons using the CYP catalytic cycle, which would 
result in an interesting alternative that facilitates biosensor development without the need of 
redox transfer proteins and cofactors (Bistolas et al., 2004; Yang et al, 2009). 
Yang et al. developed an electrochemical biosensor for the mimicry metabolism of warfarin, 
which is almost exclusively biotransformed by CYP2C9 to the primary inactive metabolite 7-
hydroxy-warfarin and to 6-hydroxy-warfarin. The system consisted of the immobilization of 
CYP2C9 onto a gold electrode through an 11-mercaptoundecanoic acid and octanethiol self-
assembled monolayer, without the presence of cofactors or other redox transfer proteins 
(figure 17). Using cyclic voltammetry, the reduction peak on the forward scan suggested the 
direct electron transfer from the electrode to the heme group of the enzyme and the 
consequent oxidation of the substrate, whereas the peak on the reverse scan indicated the re-
oxidation of the reduced enzyme. The electrochemical behavior of this system demonstrated 
that warfarin was oxidized by CYP2C9. By controlled potential electrolysis and analysis of 
the electrolyzed solution using LC, the metabolite 7-hydroxywarfarin was identified, which 
was also obtained in an in vitro enzymatic assay (Yang et al, 2009). Thus, the developed 
system was efficient in the generation of the main metabolite of warfarin and therefore 
could be used to mimic oxidative drug metabolism in a more accurate form, without the 
necessity of enzymatic cofactors. 
 
Fig. 17. A) Schematic representation of the CYP2C9 biosensor and the electrochemical 
oxidation of warfarin catalyzed enzymatically (adapted from Bistolas et al., 2005). B) 
Catalytic cycle of the CYP heme group and the reactions of the oxidation process (adapted 
from Lohmann & Karst, 2008). 
www.intechopen.com
 
Topics on Drug Metabolism 
 
242 
A similar metabolic biosensor using the more predominant isoform of cytochrome P450 
CYP3A4 was developed based on the redox properties and electronic transfer of the heme 
protein. In this case, the alternate adsorption of a CYP3A4 layer on top of a polycation layer 
was assembled onto gold electrodes. Under anaerobic conditions, a reversible electron 
transfer between the electrode and CYP3A4 was observed using cyclic voltammetry. 
However, in the presence of oxygen, the reduction peak increased 2- to 3-fold, and the 
oxidation peak of the hemoprotein disappeared. The addition of CYP3A4 substrates, such as 
verapamil, midazolam, quinidine and progesterone, to the oxygenated solution caused a 
concentration-dependent increase in the reduction current in cyclic voltammetric and 
amperometric experiments, which indicated an interaction between the enzyme and 
substrate. Controlled potential electrolysis of verapamil and midazolam and analysis by LC-
MS revealed that the metabolites generated by this system were comparable to those 
produced by the microsomal incubation of human CYP3A4 with an NADPH-generating 
system. In addition, the presence of ketoconazole or catalase in the medium inhibited the 
catalytic activity of the enzyme and consequently led to a reduction in the amount of 
metabolites generated. Thus, important information was obtained from this system in the 
evaluation of new drugs as potential substrates or inhibitors of CYP3A4 (Joseph et al., 2003). 
Inhibition and induction studies of metabolic enzymes are important in drug development 
processes because they can modulate or change the toxicity related to a drug. In this sense, 
Hull et al. developed an electrochemical biosensor to screen the metabolic inhibition of 
xenobiotics. This device consisted of films of bacterial cytochrome P450cam and DNA on a 
pyrolytic graphite electrode using a Ru(bpy)32+ complex as a mediator of DNA voltammetric 
oxidation. For this study, styrene was chosen as the enzymatic substrate because its 
metabolite is genotoxic toward guanine in DNA. Styrene metabolism initiated by hydrogen 
peroxide was evaluated with and without the following inhibitors: imidazole, imidazole-4-
acetic acid and sulconazole. The initial rates of DNA damage decreased with increasing 
inhibitor concentrations, and the calculated inhibition constants were directly related to the 
changes in styrene metabolism and DNA adduct formation in the presence of the inhibitor, 
which confirmed the usefulness of this enzyme/DNA biosensor as a rapid screening tool for 
metabolic inhibition studies of pharmaceutical candidates (Hull et al., 2009). 
Therefore, modified electrodes with metabolic enzymes could provide significant 
information about metabolism, drug-drug metabolic interactions and whether a drug is the 
substrate of a specific enzymatic isoform. Furthermore, the possibility of incorporating 
different biomolecules into this system may provide additional advantages to the study of 
drug toxicity. In this sense, DNA biosensors that have been developed could be used in the 
future to assess the genotoxicity of drug metabolites. 
6. Conclusions 
The use of electrochemistry, a purely instrumental technique, has emerged as an interesting 
alternative to generate and detect metabolites in drug development processes because it can 
mimic the main oxidative reactions that occur in the human body, providing a good 
approximation of what occurs in vivo. However, it is important to take into account that not 
all compounds can be electrochemically oxidized; therefore, a complementary approach to 
this system is necessary, such as the incorporation of enzymes useful for studying 
metabolism. 
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Electrochemistry exhibits certain advantages compared to conventional methods because it 
allows the generation and direct identification, in a rapid and clean manner, of both stable 
species and metabolites with short half-lives without the need to use laboratory animals or 
organ extracts. Additionally, it can be a powerful tool in the interaction studies with specific 
cellular components, which is more difficult to realize with in vivo or in vitro methods. 
In the future, this technique will most likely be supplemented with different enzymes or 
cofactors to expand its coverage to all metabolic reactions. It appears that biosensors could 
follow that trajectory to an increase in coverage and specificity. Additionally, the 
development of biosensors based on the use of metabolic enzymes and a biomolecular target 
that is susceptible to damage by the generated metabolites is a promising strategy to 
investigate enzyme inhibition in future metabolism studies. 
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